| Stage | ARXS | % of rev | ULS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $564M | 100.00% | $823M | 100.00% | ULS ×1.46 |
| Gross profit | $306M | 54.27% | $423M | 51.40% | ARXS +2.9pp |
| Operating income | $133M | 23.66% | $162M | 19.68% | ARXS +4.0pp |
| Pre-tax income | $120M | 21.23% | $160M | 19.44% | ARXS +1.8pp |
| Net income | $84M | 14.84% | $117M | 14.22% | ARXS +0.6pp |
| Stage | ARXS | ULS | Gap · A − B |
|---|---|---|---|
| Revenue | $564M100.00% | $823M100.00% | ULS ×1.46 |
| Gross profit | 54.27%$306M | 51.40%$423M | ARXS +2.9pp |
| Operating income | 23.66%$133M | 19.68%$162M | ARXS +4.0pp |
| Pre-tax income | 21.23%$120M | 19.44%$160M | ARXS +1.8pp |
| Net income |
| 14.84%$84M |
| 14.22%$117M |
| ARXS +0.6pp |
None
No disclosed counterparties: ARXS.